These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2770138)

  • 1. [The effect of troxevasin on the aggregation capability of thrombocytes in children under 3 years of age with various forms of acute suppurative destructive pneumonia].
    Topuzov VS; Bevz SI; Chuĭko VA; Kolesnik OV; Diagelev II
    Klin Khir (1962); 1989; (6):26-7. PubMed ID: 2770138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of troxerutin on platelet aggregation in patients with arteriosclerosis].
    Myśliwiec M; Bodzenta A
    Pol Tyg Lek; 1983 Oct; 38(44):1367-8. PubMed ID: 6674961
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of some semisynthetic rutoside derivatives on human platelets.
    Kahlé LH; Dannijs GJ; Ten Cate JW
    Bibl Anat; 1975; 13():263-4. PubMed ID: 1231745
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy of troxerutin on the flow properties of blood under defined conditions of circulation. A double-blind study of patients with diabetic retinopathy and arteriosclerotic retinopathy].
    Gallasch G; Dörfer C; Schmitt T; Stage A
    Klin Monbl Augenheilkd; 1985 Jul; 187(1):30-5. PubMed ID: 3906246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticatatonic effect of venoruton.
    Aley KO; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1988 Apr; 10(4):263-5. PubMed ID: 2898576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Do troxerutin and sodium rutin sulfate still possess the properties of rutin?].
    Brasseur T; Angenot L; Pincemail J; Deby C
    Ann Pharm Fr; 1987; 45(4):329-34. PubMed ID: 3445996
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemostatic disorder in acute pneumonia and its correction].
    Bobkova VI; Makarov VA; Martusevich IN; Solomonova LN; Kupriianova NV
    Sov Med; 1984; (1):87-90. PubMed ID: 6701661
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical effect of high doses of o-betahydroxyethyl-rutosides in patients with occlusive arterial disease.
    Bielawiec M; Lukjan H; Kiersnowska-Rogowska B; Dabrowski S
    Bibl Anat; 1979; (18):378-81. PubMed ID: 496871
    [No Abstract]   [Full Text] [Related]  

  • 9. [The behavior of blood clotting and its inhibitors under long term treatment with 5,6-benzo-alpha-pyrone (coumarin). Double blind study].
    Köstering H; Bandura B; Merten HA; Wieding JU
    Arzneimittelforschung; 1985; 35(8):1303-6. PubMed ID: 3907641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibiotic treatment of complicated forms of acute suppurative destructive pneumonia in children].
    Sergeev VM; Sakharova AE; Matveeva ES; Bodunkova LE
    Sov Med; 1980; (12):22-6. PubMed ID: 7221713
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of tri- and tetra-O-(beta-hydroxyethyl)-rutoside on red blood cell aggregation of human blood.
    van Haeringen NJ
    Bibl Anat; 1975; 13():197-9. PubMed ID: 1231726
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of Troxerutin on the hemorheological parameters of patients with moderate arterial hypertension.
    Gueguen-Duchesne M; Durand F; Le Goff MC; Genetet B
    Prog Clin Biol Res; 1988; 280():401-6. PubMed ID: 3174703
    [No Abstract]   [Full Text] [Related]  

  • 13. Venoruton in the therapy of central retinal vein occlusion.
    Zygulska-Mach H; Kostka-Trabka E; Kielar J; Grodzinska L; Dieron K; Kedzior A
    Ther Hung; 1985; 33(2):79-82. PubMed ID: 3842005
    [No Abstract]   [Full Text] [Related]  

  • 14. New pharmacological and clinical properties of the venoactive agent: Venoruton (Paroven). Studies presented at the 1st Mediterranean Congress of Angiology. Corfu, Greece, May 29 to June 3, 1988. Abstracts.
    Int Angiol; 1988; 7(4 Suppl):1-16. PubMed ID: 3249081
    [No Abstract]   [Full Text] [Related]  

  • 15. [Venalot used in therapy of phlebopathies].
    Lacativa AS
    Med Welt; 1980 May; 31(19):727-9. PubMed ID: 7421506
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of sudden deafness of vascular etiology with venoruton].
    Madej S
    Otolaryngol Pol; 1989; 43(3):214-7. PubMed ID: 2695884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of hydroxyethylrutoside and its combination with acetylsalicylic acid in patients with obliterative atherosclerosis.
    Roztocil K; Oliva I; Prerovský I; Linhart J
    Cor Vasa; 1989; 31(2):128-33. PubMed ID: 2663343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Venalot depot in episiotomy. A prospective, consecutive, double-blind study].
    Pedersen KO; Kristensen OK; Gram-Hansen J
    Ugeskr Laeger; 1982 Jan; 144(2):92-3. PubMed ID: 7043841
    [No Abstract]   [Full Text] [Related]  

  • 19. Benzopyrones in treatment of schizophrenia.
    Casley-Smith JR
    Lancet; 1983 Feb; 1(8321):421. PubMed ID: 6130413
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of troxerutin on bronchial spasm induced by inhalation of a specific allergen and on the neutrophil activity in patients with atopic bronchial asthma].
    Sładek K; Nizanowska E; Podolec Z; Wandzilak M; Dworski R; Grzywacz M; Szczeklik A
    Pol Tyg Lek; 1987 Jul; 42(29):874-6. PubMed ID: 3684767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.